DE602007009085D1 - Neues verfahren zur synthese von 2-aminooxazolverbindungen - Google Patents

Neues verfahren zur synthese von 2-aminooxazolverbindungen

Info

Publication number
DE602007009085D1
DE602007009085D1 DE602007009085T DE602007009085T DE602007009085D1 DE 602007009085 D1 DE602007009085 D1 DE 602007009085D1 DE 602007009085 T DE602007009085 T DE 602007009085T DE 602007009085 T DE602007009085 T DE 602007009085T DE 602007009085 D1 DE602007009085 D1 DE 602007009085D1
Authority
DE
Germany
Prior art keywords
compounds
oxazo
synthesis
amino
new procedure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602007009085T
Other languages
English (en)
Inventor
Abdellah Benjahad
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AB Science SA
Original Assignee
AB Science SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AB Science SA filed Critical AB Science SA
Publication of DE602007009085D1 publication Critical patent/DE602007009085D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/48—Nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DE602007009085T 2006-05-12 2007-05-11 Neues verfahren zur synthese von 2-aminooxazolverbindungen Active DE602007009085D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US79967406P 2006-05-12 2006-05-12
PCT/EP2007/054564 WO2007131953A1 (en) 2006-05-12 2007-05-11 A new process for the synthesis of 2-aminoxazole compounds

Publications (1)

Publication Number Publication Date
DE602007009085D1 true DE602007009085D1 (de) 2010-10-21

Family

ID=38268842

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602007009085T Active DE602007009085D1 (de) 2006-05-12 2007-05-11 Neues verfahren zur synthese von 2-aminooxazolverbindungen

Country Status (7)

Country Link
US (1) US8080669B2 (de)
EP (1) EP2019822B1 (de)
AT (1) ATE480525T1 (de)
DE (1) DE602007009085D1 (de)
ES (1) ES2352320T3 (de)
HK (1) HK1126777A1 (de)
WO (1) WO2007131953A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0709031D0 (en) 2007-05-10 2007-06-20 Sareum Ltd Pharmaceutical compounds
EA019104B1 (ru) 2007-09-21 2014-01-30 Эррей Биофарма Инк. Активаторы глюкокиназы
JP5328816B2 (ja) 2008-02-22 2013-10-30 エフ．ホフマン−ラ ロシュ アーゲー アミロイドβの調節薬
UA103319C2 (en) 2008-05-06 2013-10-10 Глаксосмитклайн Ллк Thiazole- and oxazole-benzene sulfonamide compounds
CN102177151A (zh) 2008-10-09 2011-09-07 弗·哈夫曼-拉罗切有限公司 β-淀粉样蛋白的调节剂
CN102209537A (zh) 2008-11-10 2011-10-05 弗·哈夫曼-拉罗切有限公司 杂环γ分泌酶调节剂
GB0820819D0 (en) 2008-11-13 2008-12-24 Sareum Ltd Pharmaceutical compounds
US8486967B2 (en) 2010-02-17 2013-07-16 Hoffmann-La Roche Inc. Heteroaryl substituted piperidines
CN103140483B (zh) 2010-07-15 2015-06-24 拜耳知识产权有限责任公司 作为杀虫剂的新杂环化合物
EP2714667B1 (de) 2011-05-27 2020-11-25 Laxman S. DESAI Aminooxazolhemmer von cyclinabhängigen kinasen
AU2012288900B2 (en) 2011-07-27 2016-10-06 Ab Science Selective protein kinase inhibitors
GB201202027D0 (en) 2012-02-06 2012-03-21 Sareum Ltd Pharmaceutical compounds
DK3040336T3 (da) 2012-03-02 2020-06-22 Sareum Ltd Forbindelser til brug i behandling af TYK2 Kinase-medierede tilstande
EP3053920B1 (de) 2015-02-05 2020-04-08 AB Science Verbindungen mit antitumoraktivität
GB201617871D0 (en) 2016-10-21 2016-12-07 Sareum Limited Pharmaceutical compounds
CN110041285B (zh) * 2019-04-29 2021-08-20 大连理工大学 一种2，4，5-三取代噁唑类化合物的制备方法
WO2022234069A1 (en) 2021-05-07 2022-11-10 Ab Science Novel 2-aminooxazoles derivatives and use thereof for treating infectious diseases

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050228031A1 (en) * 2004-04-13 2005-10-13 Bilodeau Mark T Tyrosine kinase inhibitors

Also Published As

Publication number Publication date
EP2019822B1 (de) 2010-09-08
EP2019822A1 (de) 2009-02-04
ES2352320T3 (es) 2011-02-17
US8080669B2 (en) 2011-12-20
HK1126777A1 (en) 2009-09-11
WO2007131953A1 (en) 2007-11-22
ATE480525T1 (de) 2010-09-15
US20090192317A1 (en) 2009-07-30

Similar Documents

Publication Publication Date Title
DE602007009085D1 (de) Neues verfahren zur synthese von 2-aminooxazolverbindungen
SI1711481T2 (sl) Postopek za pripravo 2-aminotiazoli-5-aromatiäśnih karboksamidov kot kinazni inhibitorji
EA201000149A1 (ru) Производные 1-фенил-2-пиридинилалкиловых спиртов в качестве ингибиторов фосфодиэстераз
MX2011006503A (es) Derivados de pirazina utiles como inhibidores de la cinasa de atr.
MX2011004953A (es) Compuestos utiles como inhibidores de cinasa atr.
HRP20090213A2 (en) Process and intermediates for preparing integrase inhibitors
EA201991779A2 (ru) Способы получения ингибиторов jak киназ и родственных промежуточных соединений
TW201713640A (en) Bruton's tyrosine kinase inhibitors
ATE522518T1 (de) Indazol- und isoindolderivate als glucokinaseaktivierende stoffe
TN2009000128A1 (en) Dihydropyridine derivatives useful as protein kinase inhibitors
GEP20115306B (de)
MY150596A (en) Hsp90 inhibitors
TN2009000342A1 (en) Process for the synthesis of 2- aminothiazole compounds as kinase inhibitors
WO2005076990A3 (en) Process for preparing 2-aminothiazole-5-carboxamides useful as kinase inhibitors
DE602005022099D1 (de) Fluorisierungsverfahren zur synthese von 2-ä18fü fluoro-2-deoxy-d-glukose
MX2008011175A (es) Inhibidores de fosfodiesterasa 10.
WO2008061108A3 (en) Phthalazine derivatives
MX2007007446A (es) Procesos para la produccion de 4-aminoquinazolinas.
TNSN06260A1 (en) Process for the preparation of tryptase inhibitors
EA201100696A1 (ru) 1-(арилсульфонил)-4-(пиперазин-1-ил)-1h-бензимидазолы в качестве лигандов 5-гидрокситриптамина-6
EA200702428A1 (ru) Способы получения 4-бифенилилазетидин-2-онов
MY150988A (en) Novel derivatives of ( bridged piperazinyl)-1-alkanone and use thereof as p75 inhibitors
NO20080160L (no) Mellomprodukter nyttige i syntesene av alkylkinolin og alkylkinazolin kinasemodulatorer og beslektede fremgangsmater for synteser
DE502006003169D1 (de) Verfahren zur enzymatischen Synthese von Triglyceriden
EA200970361A1 (ru) Ингибиторы киназы